Back to search

Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer

Data up to Jan 2025

Published2004
Citations162
References78

Total Citations Per Year

Abstract

References (78)

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

2002 • 18,672 citations

AJCC Cancer Staging Manual

2016 • 16,972 citations

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 • 10,602 citations

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1998 • 4,104 citations

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform

2004 • 3,585 citations

The polycomb group protein EZH2 is involved in progression of prostate cancer

2002 • 2,600 citations

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

2001 • 2,560 citations

Gene expression correlates of clinical prostate cancer behavior

2002 • 2,504 citations

Prediction of central nervous system embryonal tumour outcome based on gene expression

2002 • 2,359 citations

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

1998 • 2,266 citations

Gene-expression profiles predict survival of patients with lung adenocarcinoma

2002 • 2,005 citations

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

2002 • 1,959 citations

Delineation of prognostic biomarkers in prostate cancer

2001 • 1,694 citations

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

2003 • 1,587 citations

Diversity of gene expression in adenocarcinoma of the lung

2001 • 1,299 citations

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

2002 • 1,114 citations

Classification of prostatic carcinomas.

1966 • 1,101 citations

Assembly of microarrays for genome-wide measurement of DNA copy number

2001 • 948 citations

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

2001 • 860 citations

Gene Expression Patterns in Human Liver Cancers

2002 • 810 citations

Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

2001 • 672 citations

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

1998 • 672 citations

Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

2002 • 656 citations

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

1999 • 606 citations

Real-time quantitative RT–PCR after laser-assisted cell picking

1998 • 578 citations

Large-scale genotyping of complex DNA

2003 • 577 citations

An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

2004 • 558 citations

Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

1995 • 490 citations

Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.

2001 • 489 citations

Identifying distinct classes of bladder carcinoma using microarrays

2002 • 487 citations

The program of androgen-responsive genes in neoplastic prostate epithelium

2002 • 473 citations

Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

1997 • 443 citations

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

2001 • 431 citations

Expression profiling reveals hepsin overexpression in prostate cancer.

2001 • 393 citations

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data

2004 • 383 citations

Distinct Transcriptional Profiles of Adrenocortical Tumors Uncovered by DNA Microarray Analysis

2003 • 378 citations

Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis

2002 • 318 citations

Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas

1998 • 314 citations

Alpha-Methylacyl-CoA Racemase

2002 • 285 citations

Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

2000 • 227 citations

Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.

2003 • 207 citations

Prognostic significance of c‐myc and AIB1 amplification in hepatocellular carcinoma

2002 • 197 citations

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer

1994 • 195 citations

Transcriptional programs activated by exposure of human prostate cancer cells to androgen

2002 • 192 citations

MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS COMPARED TO BENIGN PROSTATIC HYPERPLASIA

2001 • 189 citations

Neuroendocrine expression in metastaticprostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression

2000 • 183 citations

E-cadherin expression in prostate cancer: A broad survey using high-density tissue microarray technology

2001 • 176 citations

Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.

1995 • 171 citations

Dysregulation of the Annexin Family Protein Family Is Associated with Prostate Cancer Progression

2003 • 171 citations

Quantitative Determination of Expression of the Prostate Cancer Protein α-Methylacyl-CoA Racemase Using Automated Quantitative Analysis (AQUA)

2004 • 150 citations

Amplification and Overexpression of p40 Subunit of Eukaryotic Translation Initiation Factor 3 in Breast and Prostate Cancer

1999 • 146 citations

Expression profiling of CD34 + hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia

2002 • 142 citations

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis

2002 • 141 citations

Global Expression Changes of Constitutive and Hormonally Regulated Genes during Endometrial Neoplastic Transformation

2001 • 139 citations

Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization

1995 • 129 citations

Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.

2003 • 126 citations

Coamplification of prostate stem cell antigen (PSCA) andMYC in locally advanced prostate cancer

2000 • 118 citations

Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.

1994 • 118 citations

Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer

2001 • 114 citations

A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence.

1995 • 108 citations

PrLZ, a Novel Prostate-Specific and Androgen-Responsive Gene of the TPD52 Family, Amplified in Chromosome 8q21.1 and Overexpressed in Human Prostate Cancer

2004 • 104 citations

The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma

2000 • 93 citations

Tissue Microarray Assessment of Prostate Cancer Tumor Proliferation in African- American and White Men

2000 • 86 citations

High-Resolution Analysis of Paraffin-Embedded and Formalin-Fixed Prostate Tumors Using Comparative Genomic Hybridization to Genomic Microarrays

2003 • 78 citations

Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma

1997 • 76 citations

Histologic grade, clinical stage, and patient age in prostate cancer.

1988 • 73 citations

8p22> loss concurrent with 8c gain is associated with poor outcome in prostate cancer

2000 • 69 citations

Amplification and Overexpression of Elongin C Gene Discovered in Prostate Cancer by cDNA Microarrays

2002 • 67 citations

Mapping the amplification ofEIF3S3 in breast and prostate cancer

2000 • 48 citations

Genetic Evaluation of Localized Prostate Cancer in a Cohort of Forty Patients: Gain Of Distal 8q Discriminates Between Progressors and Nonprogressors

2003 • 42 citations

Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.

2002 • 41 citations

Alternative Splicing as a Mechanism for Regulating 14-3-3 Binding: Interactions between hD53 (TPD52L1) and 14-3-3 Proteins

2003 • 40 citations

Changes in Keratin Expression during the Development of Benign Prostatic Hyperplasia

1997 • 24 citations

A novel tumorigenic human prostate epithelial cell line (M2205)

2003 • 15 citations

Expression of cytokeratin-19 as a marker of neoplastic progression of human prostate epithelial cells

1998 • 14 citations

Fluorescent in Situ Hybridization Study of c-myc Oncogene Copy Number in Prostate Cancer

2000 • 12 citations

The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate

2003 • 9 citations

Cited By (0)

Loading...
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer (2004) – Cancer Research | Metascience Observatory Explorer